Related Experiment Videos

Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2

D J Brown1, P Bishop, H Hamdi

  • 1Department of Surgery, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, University of California at Los Angeles Medical School Affiliate 90048, USA.

Current Eye Research
|April 1, 1996
PubMed

Insights

Matrix metalloproteinase-2 (MMP-2) can degrade specific collagen types in the vitreous, potentially causing vitreous liquefaction observed in aging and disease.

Area of Science:

  • Ophthalmology
  • Biochemistry
  • Molecular Biology

Background:

  • The vitreous body is composed of a collagenous matrix.
  • Matrix metalloproteinases (MMPs) are enzymes capable of degrading extracellular matrix components.
  • Matrix metalloproteinase-2 (MMP-2) is a major endogenous protease found in the vitreous.

Purpose of the Study:

  • To investigate the capacity of endogenous vitreous matrix metalloproteinase-2 (MMP-2) to degrade collagenous components of the vitreous body.
  • To determine if MMP-2 activity contributes to vitreous liquefaction.

Main Methods:

  • Isolation and purification of matrix metalloproteinase-2 (MMP-2) and its inhibitors from porcine vitreous.
  • Activation of latent MMP-2 using p-aminophenyl mercuric acetate (APMA).
  • Isolation of bovine vitreous fibrillar collagens (types II, V/XI, and IX) and incubation with activated MMP-2.
  • Analysis of collagen degradation and vitreous gel liquefaction in vitro.

Main Results:

  • Activated MMP-2 degraded type V/XI collagen and type IX collagen fragments.
  • MMP-2 selectively digested alpha 3 (IX) chains of intact helical type IX collagen.
  • MMP-2 disrupted vitreous gels in vitro, releasing proteins but not glycosaminoglycans.

Conclusions:

  • Vitreous matrix metalloproteinase-2 (MMP-2) preferentially cleaves specific collagen chains, leading to large fragments.
  • MMP-2 activity is a potential mechanism driving vitreous liquefaction associated with aging and pathological conditions.
  • MMP-2's role in degrading vitreous collagen warrants further consideration in ocular disease pathogenesis.

Related Concept Videos